Royalty Pharma plc (NASDAQ:RPRX) Receives $41.67 Consensus

3 days ago  · Royalty Pharma plc (NASDAQ:RPRX - Get Free Report) has been given a consensus recommendation of "Buy" by the seven research firms that are presently covering …


$41.67
OFF

Royalty Pharma Plc (NASDAQ:RPRX) Receives $41.67 Consensus

2 weeks from now

3 days ago  · Royalty Pharma plc (NASDAQ:RPRX - Get Free Report) has been given a consensus recommendation of "Buy" by the seven research firms that are presently covering …

marketbeat.com

$24.92
OFF

Analysts Set Royalty Pharma Plc (NASDAQ:RPRX) Price Target At …

2 weeks from now

Dec 21, 2024  · Shares of RPRX opened at $24.92 on Wednesday. The stock has a 50 day moving average price of $26.43 and a 200 day moving average price of $27.15. Royalty …

etfdailynews.com

$41.67
OFF

Royalty Pharma Plc (NASDAQ:RPRX) Receives $41.67 Consensus …

2 weeks from now

Nov 26, 2024  · Royalty Pharma plc (NASDAQ:RPRX – Get Free Report) has been given a consensus recommendation of “Moderate Buy” by the six ratings firms that are covering the …

etfdailynews.com

$1.04
OFF

Royalty Pharma (RPRX) Q3 Earnings And Revenues Surpass Estimates

2 weeks from now

Nov 6, 2024  · Royalty Pharma (RPRX) came out with quarterly earnings of $1.04 per share, beating the Zacks Consensus Estimate of $0.95 per share. This compares to earnings of …

nasdaq.com

20%
OFF

What Makes Royalty Pharma (RPRX) A New Buy Stock

2 weeks from now

Oct 8, 2024  · The upgrade of Royalty Pharma to a Zacks Rank #2 positions it in the top 20% of the Zacks-covered stocks in terms of estimate revisions, implying that the stock might move …

nasdaq.com

$0.96
OFF

Royalty Pharma (RPRX) Earnings Expected To Grow: Should You Buy?

2 weeks from now

Aug 1, 2024  · For the last reported quarter, it was expected that Royalty Pharma would post earnings of $0.96 per share when it actually produced earnings of $0.98, delivering a surprise …

nasdaq.com

$29.49
OFF

Here’s Why Royalty Pharma Plc (RPRX) Led This Week’s Rally

2 weeks from now

2 days ago  · Royalty Pharma plc (NASDAQ:RPRX) saw its share price increase by 14.26 percent to end at $29.49 apiece versus the $25.81 posted the week prior, following news that it was …

yahoo.com

16%
OFF

Royalty Pharma: Key Strategic Updates To Be Priced In

2 weeks from now

5 hours ago  · Following our Strong Buy suggestion in early November 2024, Royalty Pharma plc (NASDAQ:RPRX) stock price increased by more than 16%, with a clear outperformance over …

seekingalpha.com

$100
OFF

Royalty Pharma Announces Transformative Step In Company’s …

2 weeks from now

5 days ago  · Royalty Pharma will acquire the Manager for approximately 24.5 million shares of Royalty Pharma equity that will vest over 5 to 9 years, approximately $100 million in cash [1], …

royaltypharma.com

$3000
OFF

Royalty Pharma Plc Announces An Equity Buyback For $3,000 …

2 weeks from now

5 days ago  · Royalty Pharma plc announces a share repurchase program. Under the program, the company will repurchase up to $3,000 million worth of its shares. ... PureTech Health plc …

marketscreener.com

$2.36
OFF

Pallas Capital Advisors LLC Invests $2.36 Million In Royalty Pharma …

2 weeks from now

2 days ago  · Pallas Capital Advisors LLC purchased a new position in Royalty Pharma plc (NASDAQ:RPRX - Free Report) in the fourth quarter, according to the company in its most …

marketbeat.com

13%
OFF

Royalty Pharma Hits Record $2.8B In Deals, Projects $1.2B Peak …

2 weeks from now

5 days ago  · Royalty Pharma (RPRX) expects 2024 Portfolio Receipts of approximately $2.8 billion, reaching the upper end of guidance, driven by ~13% year-over-year growth in Royalty …

stocktitan.net

$24.05
OFF

JPMorgan Chase & Co. Trims Stake In Royalty Pharma Plc …

2 weeks from now

Jan 7, 2025  · Royalty Pharma plc has a 12-month low of $24.05 and a 12-month high of $31.66. The firm has a market cap of $15.17 billion, a price-to-earnings ratio of 13.34, a PEG ratio of …

etfdailynews.com

5%
OFF

Royalty Pharma Plc Declares 5% Increase In Quarterly Dividend

2 weeks from now

5 days ago  · Royalty Pharma declares a $0.22 dividend per share for Q1 2025, a 5% increase from the previous quarter. Royalty Pharma plc has announced a quarterly dividend of $0.22 …

nasdaq.com

FAQs about Royalty Pharma plc (NASDAQ:RPRX) Receives $41.67 Consensus Coupon?

Should you buy Royalty Pharma plc (RPRX)?

Royalty Pharma plc (NASDAQ:RPRX – Get Free Report) has received a consensus rating of “Buy” from the seven ratings firms that are presently covering the stock, Marketbeat Ratings reports. One analyst has rated the stock with a hold recommendation, five have given a buy recommendation and one has issued a strong buy recommendation on the company. ...

Is Royalty Pharma a good buy?

Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Royalty Pharma has received a consensus rating of Moderate Buy. The company's average rating score is 2.83, and is based on 5 buy ratings, 1 hold rating, and no sell ratings. ...

What is the target price for Royalty Pharma (RPRX)?

The average 12-month target price among brokerages that have covered the stock in the last year is $41.67. Several brokerages have issued reports on RPRX. StockNews.com raised shares of Royalty Pharma from a “hold” rating to a “buy” rating in a research note on Tuesday, November 5th. ...

Why did Royalty Pharma (RPRX) increase its share price?

Royalty Pharma plc (NASDAQ:RPRX) saw its share price increase by 14.26 percent to end at $29.49 apiece versus the $25.81 posted the week prior, following news that it was set to acquire its external manager RP Management, as it seeks to simplify its corporate structure. ...

How did Royalty Pharma's stock perform in 2024?

Royalty Pharma's stock was trading at $28.09 at the beginning of 2024. Since then, RPRX stock has decreased by 11.6% and is now trading at $24.84. How were Royalty Pharma's earnings last quarter? Royalty Pharma plc (NASDAQ:RPRX) announced its quarterly earnings results on Thursday, August, 8th. ...

How do I receive news & ratings for Royalty Pharma?

Receive News & Ratings for Royalty Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Royalty Pharma and related companies with MarketBeat.com's FREE daily email newsletter. ...

Install CouponFollow Extension on Chrome

Install the CouponFollow extension to search for discount codes when shopping the fastest!

Install CouponFollow Chrome Extension   Install CouponFollow Chrome Extension